Vankomicin (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vankomicin" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

23nih.gov

4^th place

8^th place

13doi.org

2^nd place

5^th place

9archive.org

6^th place

9^th place

3web.archive.org

1^st place

2^nd place

2jbc.org

4,455^th place

898^th place

1zdravila.net

low place

5,211^th place

1cdc.gov

218^th place

83^rd place

1nursingcenter.com

low place

1pubmedcentral.gov

low place

7,615^th place

1ajhp.org

low place

5,587^th place

ajhp.org

Rybak M; Lomaestro B; Rotschafer JC; in sod. (2009). »Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists«. American Journal of Health-System Pharmacy. 66 (1): 82–98. doi:10.2146/ajhp080434. PMID 19106348.

archive.org

Small PM; Chambers HF (1990). »Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users«. Antimicrob Agents Chemother. 34 (6): 1227–31. PMC 171789. PMID 2393284.
Gonzalez C; Rubio M; Romero-Vivas J; Gonzalez M; Picazo JJ (1999). »Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms«. Clin Infect Dis. 29 (5): 1171–7. doi:10.1086/313440. PMID 10524959.
Cantú TG; Yamanaka-Yuen NA; Lietman PS (1994). »Serum vancomycin concentrations: reappraisal of their clinical value«. Clin Infect Dis. 18 (4): 533–43. PMID 8038306.
Farber BF; Moellering RC Jr. (1983). »Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981«. Antimicrob Agents Chemother. 23 (1): 138. PMC 184631. PMID 6219616.
Edlund C; Barkholt L; Olsson-Liljequist B; Nord CE (1997). »Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy«. Clin Infect Dis. 25: 729–32. doi:10.1086/513755.
Peláez T; Alcalá L; Alonso R; in sod. (2002). »Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin«. Antimicrob Agents Chemother. 46 (6): 1647–1650. doi:10.1128/AAC.46.6.1647-1650.2002.
Geraci J (1977). »Vancomycin«. Mayo Clin Proc. 52 (10): 631–4. PMID 909314.
Swenson JM; Facklam RR; Thornsberry C (1990). »Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus and Lactobacillus species«. Antimicrob Agents Chemother. 34: 543–49.
Quintiliani R Jr; Courvalin P (1995). »Mechanisms of Resistance to Antimicrobial Agents«. V Murray PR; Baron EJ; Pfaller MA; Tenover FC; Yolken RH (ur.). Manual of Clinical Microbiology (6 izd.). Washington DC: ASM Press. str. 1319. ISBN 1-55581-086-1.

cdc.gov

wonder.cdc.gov

http://wonder.cdc.gov/wonder/prevguid/m0039349/m0039349.asp Arhivirano 2006-09-23 na Wayback Machine..

doi.org

Levine, D. (2006). »Vancomycin: A History«. Clin Infect Dis. 42: S5–S12. doi:10.1086/491709. PMID 16323120.
Moellering, RC Jr. (2006). »Vancomycin: A 50-Year Reassessment«. Clin Infect Dis. 42 (Suppl 1): S3–S4. doi:10.1086/491708. PMID 16323117.
Samel SA; Marahiel MA; Essen LO (Maj 2008). »How to tailor non-ribosomal peptide products-new clues about the structures and mechanisms of modifying enzymes«. Mol Biosyst. 4 (5): 387–93. doi:10.1039/b717538h. PMID 18414736.
van Wageningen AM; Kirkpatrick PN; Williams DH; in sod. (Marec 1998). »Sequencing and analysis of genes involved in the biosynthesis of a vancomycin group antibiotic«. Chem. Biol. 5 (3): 155–62. doi:10.1016/S1074-5521(98)90060-6. PMID 9545426.
Stein T; Vater J; Kruft V; in sod. (Junij 1996). »The multiple carrier model of nonribosomal peptide biosynthesis at modular multienzymatic templates«. J. Biol. Chem. 271 (26): 15428–35. doi:10.1074/jbc.271.26.15428. PMID 8663196.
Kohli RM; Walsh CT; Burkart MD (Avgust 2002). »Biomimetic synthesis and optimization of cyclic peptide antibiotics«. Nature. 418 (6898): 658–61. doi:10.1038/nature00907. PMID 12167866.
Gonzalez C; Rubio M; Romero-Vivas J; Gonzalez M; Picazo JJ (1999). »Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms«. Clin Infect Dis. 29 (5): 1171–7. doi:10.1086/313440. PMID 10524959.
Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL (2009). »Relationship between initial vancomycin concentration‐time profile and nephrotoxicity among hospitalized patients«. Clin Infect Dis. 49 (4): 507–514. doi:10.1086/600884. PMID 19586413.
Drygalski A; Curtis BR (2007). »Vancomycin-Induced Immune Thrombocytopenia«. N Engl J Med. 356 (9): 904. doi:10.1056/NEJMoa065066. PMID 17329697.
Edlund C; Barkholt L; Olsson-Liljequist B; Nord CE (1997). »Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy«. Clin Infect Dis. 25: 729–32. doi:10.1086/513755.
Peláez T; Alcalá L; Alonso R; in sod. (2002). »Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin«. Antimicrob Agents Chemother. 46 (6): 1647–1650. doi:10.1128/AAC.46.6.1647-1650.2002.
Rybak M; Lomaestro B; Rotschafer JC; in sod. (2009). »Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists«. American Journal of Health-System Pharmacy. 66 (1): 82–98. doi:10.2146/ajhp080434. PMID 19106348.
Hamilton-Miller JM; Shah S (1998). »Vancomycin susceptibility as an aid to the identification of lactobacilli«. Lett Appl Microbiol. 26: 153–54. doi:10.1046/j.1472-765X.1998.00297.x.

jbc.org

Schlumbohm W; Stein T; Ullrich C; in sod. (december 1991). »An active serine is involved in covalent substrate amino acid binding at each reaction center of gramicidin S synthetase«. J. Biol. Chem. 266 (34): 23135–41. PMID 1744112.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Stein T; Vater J; Kruft V; in sod. (Junij 1996). »The multiple carrier model of nonribosomal peptide biosynthesis at modular multienzymatic templates«. J. Biol. Chem. 271 (26): 15428–35. doi:10.1074/jbc.271.26.15428. PMID 8663196.

nih.gov

pubmed.ncbi.nlm.nih.gov

Levine, D. (2006). »Vancomycin: A History«. Clin Infect Dis. 42: S5–S12. doi:10.1086/491709. PMID 16323120.
Moellering, RC Jr. (2006). »Vancomycin: A 50-Year Reassessment«. Clin Infect Dis. 42 (Suppl 1): S3–S4. doi:10.1086/491708. PMID 16323117.
Samel SA; Marahiel MA; Essen LO (Maj 2008). »How to tailor non-ribosomal peptide products-new clues about the structures and mechanisms of modifying enzymes«. Mol Biosyst. 4 (5): 387–93. doi:10.1039/b717538h. PMID 18414736.
van Wageningen AM; Kirkpatrick PN; Williams DH; in sod. (Marec 1998). »Sequencing and analysis of genes involved in the biosynthesis of a vancomycin group antibiotic«. Chem. Biol. 5 (3): 155–62. doi:10.1016/S1074-5521(98)90060-6. PMID 9545426.
Schlumbohm W; Stein T; Ullrich C; in sod. (december 1991). »An active serine is involved in covalent substrate amino acid binding at each reaction center of gramicidin S synthetase«. J. Biol. Chem. 266 (34): 23135–41. PMID 1744112.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Stein T; Vater J; Kruft V; in sod. (Junij 1996). »The multiple carrier model of nonribosomal peptide biosynthesis at modular multienzymatic templates«. J. Biol. Chem. 271 (26): 15428–35. doi:10.1074/jbc.271.26.15428. PMID 8663196.
Kohli RM; Walsh CT; Burkart MD (Avgust 2002). »Biomimetic synthesis and optimization of cyclic peptide antibiotics«. Nature. 418 (6898): 658–61. doi:10.1038/nature00907. PMID 12167866.
Small PM; Chambers HF (1990). »Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users«. Antimicrob Agents Chemother. 34 (6): 1227–31. PMC 171789. PMID 2393284.
Gonzalez C; Rubio M; Romero-Vivas J; Gonzalez M; Picazo JJ (1999). »Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms«. Clin Infect Dis. 29 (5): 1171–7. doi:10.1086/313440. PMID 10524959.
Cantú TG; Yamanaka-Yuen NA; Lietman PS (1994). »Serum vancomycin concentrations: reappraisal of their clinical value«. Clin Infect Dis. 18 (4): 533–43. PMID 8038306.
Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL (2009). »Relationship between initial vancomycin concentration‐time profile and nephrotoxicity among hospitalized patients«. Clin Infect Dis. 49 (4): 507–514. doi:10.1086/600884. PMID 19586413.
Farber BF; Moellering RC Jr. (1983). »Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981«. Antimicrob Agents Chemother. 23 (1): 138. PMC 184631. PMID 6219616.
Drygalski A; Curtis BR (2007). »Vancomycin-Induced Immune Thrombocytopenia«. N Engl J Med. 356 (9): 904. doi:10.1056/NEJMoa065066. PMID 17329697.
Geraci J (1977). »Vancomycin«. Mayo Clin Proc. 52 (10): 631–4. PMID 909314.
Rybak M; Lomaestro B; Rotschafer JC; in sod. (2009). »Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists«. American Journal of Health-System Pharmacy. 66 (1): 82–98. doi:10.2146/ajhp080434. PMID 19106348.

ncbi.nlm.nih.gov

Small PM; Chambers HF (1990). »Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users«. Antimicrob Agents Chemother. 34 (6): 1227–31. PMC 171789. PMID 2393284.
Farber BF; Moellering RC Jr. (1983). »Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981«. Antimicrob Agents Chemother. 23 (1): 138. PMC 184631. PMID 6219616.
Sivagnanam S, Deleu D. Red man syndrome. Crit Care 2003;7(2):119–120. PMID 12720556. (full text Arhivirano 2006-05-08 na Wayback Machine.)
Cantu TG, Yamanaka-Yuen NA, Lietman PS. Serum vancomycin concentrations: reappraisal of their clinical value. Clin Infect Dis 1994;19(6):1180-2. PMID 8038306
Moellering RC Jr. Monitoring serum vancomycin levels: climbing the mountain because it is there? Clin Infect Dis 1994;18(4):544-6. PMID 8038307
Karam CM, McKinnon PS, Neuhauser MM, Rybak MJ. Outcome assessment of minimizing vancomycin monitoring and dosing adjustments. Pharmacotherapy 1999;19(3):257-66. PMID 10221365
Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 1999;340(7):493–501. PMID 10021469
McDonald LC, Killgore GE, Thompson A, et al. Emergence of an epidemic, toxin gene variant strain of Clostridium difficile responsible for outbreaks in the United States between 2000 and 2004. N Engl J Med 2005;353:2433-2441. PMID 16322603

nursingcenter.com

http://www.nursingcenter.com/prodev/ce_article.asp?tid=745323

pubmedcentral.gov

Sivagnanam S, Deleu D. Red man syndrome. Crit Care 2003;7(2):119–120. PMID 12720556. (full text Arhivirano 2006-05-08 na Wayback Machine.)

web.archive.org

http://www.zdravila.net Arhivirano 2012-05-30 na Wayback Machine.: Baza podakov o zdravilih, vpogled: 26. 9. 2010.
http://wonder.cdc.gov/wonder/prevguid/m0039349/m0039349.asp Arhivirano 2006-09-23 na Wayback Machine..
Sivagnanam S, Deleu D. Red man syndrome. Crit Care 2003;7(2):119–120. PMID 12720556. (full text Arhivirano 2006-05-08 na Wayback Machine.)

zdravila.net

http://www.zdravila.net Arhivirano 2012-05-30 na Wayback Machine.: Baza podakov o zdravilih, vpogled: 26. 9. 2010.